| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |